Latest News
As COVID-19 precautions lift, other infectious diseases are poised to resurge, especially in young children who haven’t had a chance to build immunity.
Oct 15, 2021
Current Issue
-
Drug review processes in Canada are outdated and should be revised to take account of new evidence.
-
For ambulatory patients on chemotherapy who are at increased risk of VTE, apixaban is the most cost-effective anticoagulant.
-
Patients on warfarin with a head injury had a higher risk of ICH versus patients on a DOAC or no anticoagulation.
-
Inhaling or aspirating oil-based nasal and oral products can cause nonresolving pneumonia; a careful history is crucial.
-
Most patients present with severe pruritis; treatment with topical corticosteroids controls symptoms and prevents scarring.
Latest Blog Posts
Altmetric Data
- Recent cannabis use and myocardial infarction in young adults: a cross-sectional studyLast mentioned on Sat Oct 16 2021
- Evaluation of the relative virulence of novel SARS-CoV-2 variants: a retrospective cohort study in Ontario, CanadaLast mentioned on Sun Oct 17 2021
- Infectivity of severe acute respiratory syndrome coronavirus 2 in children compared with adultsLast mentioned on Sun Oct 17 2021
- More »
